Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Magari

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1994
[Molecular marker for detecting hypercoagulable state]Y Magari, S Mizunaga, M Ito, et al.
Clinical Nephrology|August 1, 1995
Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseasesT Shibata, Y Magari, P Kamberi, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|February 1, 1988
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]I Iwamoto, M Furukawa, S Ito, et al.
Nihon Jinzo Gakkai Shi|April 1, 1991
[Studies on molecular markers for hemostasis and thrombosis in various renal diseases]T Shibata, T Ishii, T Tomo, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 5, 2002
[Respiratory function tests--current and future perspective]N Sano, Y Kamiyama, S Kato, et al.
Nihon Jinzo Gakkai Shi|June 1, 1993
[Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases]T Shibata, A Sumie, T Ishii, et al.
Japanese Heart Journal|June 17, 1999
Lipoprotein(a) concentrations in healthy subjects in the Dominican Republic. Comparison with JapaneseH Aono, M Ito, H Ozawa, et al.
Nihon Jinzo Gakkai Shi|July 1, 1994
[Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases]T Shibata, Y Magari, S Mizunaga, et al.
Nephron|January 1, 1995
Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISAT Shibata, Y Magari, K Perparim, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1996
[Standardization of serum lipid examination: an attempt in Oita]Y Magari, M Sato, S Toshimitu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1994
[Molecular marker for detecting hypercoagulable state]Y Magari, S Mizunaga, M Ito, et al.
Clinical Nephrology|August 1, 1995
Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseasesT Shibata, Y Magari, P Kamberi, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|February 1, 1988
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]I Iwamoto, M Furukawa, S Ito, et al.
Nihon Jinzo Gakkai Shi|April 1, 1991
[Studies on molecular markers for hemostasis and thrombosis in various renal diseases]T Shibata, T Ishii, T Tomo, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 5, 2002
[Respiratory function tests--current and future perspective]N Sano, Y Kamiyama, S Kato, et al.
Nihon Jinzo Gakkai Shi|June 1, 1993
[Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases]T Shibata, A Sumie, T Ishii, et al.
Japanese Heart Journal|June 17, 1999
Lipoprotein(a) concentrations in healthy subjects in the Dominican Republic. Comparison with JapaneseH Aono, M Ito, H Ozawa, et al.
Nihon Jinzo Gakkai Shi|July 1, 1994
[Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases]T Shibata, Y Magari, S Mizunaga, et al.
Nephron|January 1, 1995
Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISAT Shibata, Y Magari, K Perparim, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1996
[Standardization of serum lipid examination: an attempt in Oita]Y Magari, M Sato, S Toshimitu, et al.
Pageof 1